DE60144561D1 - N- und/oder c-terminal mit kurzen geladenen peptidsequenzen modifizierte peptide - Google Patents

N- und/oder c-terminal mit kurzen geladenen peptidsequenzen modifizierte peptide

Info

Publication number
DE60144561D1
DE60144561D1 DE60144561T DE60144561T DE60144561D1 DE 60144561 D1 DE60144561 D1 DE 60144561D1 DE 60144561 T DE60144561 T DE 60144561T DE 60144561 T DE60144561 T DE 60144561T DE 60144561 D1 DE60144561 D1 DE 60144561D1
Authority
DE
Germany
Prior art keywords
trp
missing
phe
lys
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60144561T
Other languages
German (de)
English (en)
Inventor
Bjarne Due Larsen
Jorgen Soberg Petersen
Daniel R Kapusta
Kenneth William Harlow
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Serodus AS
Original Assignee
Serodus AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Serodus AS filed Critical Serodus AS
Priority claimed from PCT/US2001/041008 external-priority patent/WO2002028412A1/en
Application granted granted Critical
Publication of DE60144561D1 publication Critical patent/DE60144561D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE60144561T 2000-06-16 2001-06-15 N- und/oder c-terminal mit kurzen geladenen peptidsequenzen modifizierte peptide Expired - Lifetime DE60144561D1 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DKPA200000944 2000-06-16
DKPA200001485 2000-10-05
US25167100P 2000-12-06 2000-12-06
PCT/US2001/019113 WO2001098324A1 (en) 2000-06-16 2001-06-15 Peptide conjugates modified n- and/or c-terminally by short charged peptide chains
PCT/US2001/041008 WO2002028412A1 (en) 2000-10-05 2001-06-15 Novel use of peptide

Publications (1)

Publication Number Publication Date
DE60144561D1 true DE60144561D1 (de) 2011-06-16

Family

ID=27222400

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60144561T Expired - Lifetime DE60144561D1 (de) 2000-06-16 2001-06-15 N- und/oder c-terminal mit kurzen geladenen peptidsequenzen modifizierte peptide

Country Status (8)

Country Link
EP (1) EP1294746B1 (enExample)
JP (1) JP4624639B2 (enExample)
AT (1) ATE508138T1 (enExample)
AU (1) AU7294401A (enExample)
CA (1) CA2410224C (enExample)
CY (1) CY1111740T1 (enExample)
DE (1) DE60144561D1 (enExample)
WO (1) WO2001098324A1 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7550425B2 (en) 2000-06-16 2009-06-23 Zealand Pharma A/S Diuretic peptide conjugates
US7244701B2 (en) 2000-06-16 2007-07-17 Zealand Phama A/S Diuretic peptide conjugate
WO2003030828A2 (en) 2001-10-09 2003-04-17 Synvax, Inc. Nociceptin-based analgesics
WO2003097857A2 (en) * 2002-05-17 2003-11-27 Zealand Pharma A/S Method for the detection of aquaretic compounds
US7790681B2 (en) 2002-12-17 2010-09-07 Amylin Pharmaceuticals, Inc. Treatment of cardiac arrhythmias with GLP-1 receptor ligands
JP2006514649A (ja) * 2003-12-17 2006-05-11 アミリン・ファーマシューティカルズ，インコーポレイテッド 腎症の治療および予防のための組成物
WO2010072228A1 (en) 2008-12-22 2010-07-01 Xigen S.A. Novel transporter constructs and transporter cargo conjugate molecules
CA2807036C (en) 2010-10-14 2018-01-16 Xigen S.A. Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of chronic or non-chronic inflammatory eye diseases
WO2012065082A1 (en) * 2010-11-11 2012-05-18 Massachusetts Institute Of Technology Dendrimer-based excipients for the attentuation of protein aggregation
WO2013091670A1 (en) * 2011-12-21 2013-06-27 Xigen S.A. Novel jnk inhibitor molecules for treatment of various diseases
WO2014206427A1 (en) 2013-06-26 2014-12-31 Xigen Inflammation Ltd. New use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of various diseases
AU2014301631A1 (en) 2013-06-26 2015-08-27 Xigen Inflammation Ltd. New use of cell-permeable peptide inhibitors of the JNK signal transduction pathway for the treatment of various diseases
WO2015197097A1 (en) 2014-06-26 2015-12-30 Xigen Inflammation Ltd. New use for jnk inhibitor molecules for treatment of various diseases
EP3065757A4 (en) 2013-10-09 2017-08-23 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for downregulation of pro-inflammatory cytokines
CN103936838B (zh) * 2014-04-10 2015-10-28 武汉启瑞科技发展有限公司 小分子多肽TAT-p53DM及其在制备治疗或预防缺血性卒中药物中的应用
GB201506380D0 (en) 2015-04-15 2015-05-27 Serodus Asa Materials and methods for treatment of pulmonary hypertension
CA3209741A1 (en) * 2021-02-26 2022-09-01 Shohei Koide Compositions and methods comprising antibodies that bind to covalent peptide conjugates
WO2025037992A1 (en) * 2023-08-13 2025-02-20 Filip Majewski New peptides and use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5814603A (en) * 1992-06-12 1998-09-29 Affymax Technologies N.V. Compounds with PTH activity
AU2712999A (en) * 1998-03-05 1999-09-20 Novo Nordisk A/S Use of hexapeptides for the manufacture of a pharmaceutical composition for the treatment of hot flushes
EP1950224A3 (en) * 1998-03-09 2008-12-17 Zealand Pharma A/S Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
CN1254234C (zh) * 2000-06-09 2006-05-03 莱古伦公司 质粒dna(lipogenestm)和含细胞核定位信号/促融合肽缀合物的治疗剂包封到定向脂质体复合体中
US7459539B2 (en) * 2000-12-15 2008-12-02 Agensys, Inc. Antibody that binds zinc transporter protein 108P5H8

Also Published As

Publication number Publication date
CY1111740T1 (el) 2015-10-07
CA2410224C (en) 2013-08-13
JP4624639B2 (ja) 2011-02-02
CA2410224A1 (en) 2001-12-27
WO2001098324A8 (en) 2002-03-21
AU7294401A (en) 2002-01-02
ATE508138T1 (de) 2011-05-15
EP1294746A1 (en) 2003-03-26
EP1294746B1 (en) 2011-05-04
JP2004516811A (ja) 2004-06-10
WO2001098324A1 (en) 2001-12-27

Similar Documents

Publication Publication Date Title
CY1111740T1 (el) Συζευγματα πεπτιδιων ν- και/ή c-τελικως τροποποιημενα μεσω βραχεων αλυσων φορτισμενων πεπτιδιων
ES2194861T3 (es) Peptidos opiodes.
HUP0102900A2 (hu) Javított szilárd fázisú peptidszintézis és a szintézisben alkalmazható anyagok
KR900006363A (ko) 신규한 펩티다제 억제제
AU4799793A (en) Beta -aminoalkyl and beta -n-peptidylaminoalkyl boronic acids
DE60136373D1 (de) Neue polypeptide und anti-hiv-arzneimittel, die diese enthalten
KR870007203A (ko) 펩타이드를 제조하는 방법
GB1570210A (en) Peptides
DE69623635D1 (de) Mu-opioidligande: agonisten und antagonisten
DK0745093T3 (da) Hidtil ukendte oligopeptoder med affinitet til opioidreceptorer
GB1477001A (en) Process for the manufacture of peptides containing more han one cystine residue
NO963851D0 (no) Biotinderivater
TR199901831T2 (xx) Kollagen-II'ye �zg� bir T-h�cresi epitopundan olu�an peptitler.
Flouret et al. Improvement in potency of an oxytocin antagonist after systematic substitutions with L-tryptophan
CS207570B2 (en) Method of making the tetradecapeptide
Lepša et al. Acidic Cleavage of the Side Chain Protecting Groups of Peptides Attached to a Modified Polystyrene Carrier: Synthesis of Peptide Generics
KR870007206A (ko) 폴리펩타이드 화합물
ATE17585T1 (de) Peptide.
KR910004663A (ko) 정신-약리학적 펩티드